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Abstract—The dynamic nature of blood flow during hyperthermia therapy has made the control 
of minimum tumor temperature a difficult task. This paper presents initial studies of a novel 
approach to closed-loop control of local minimum tissue temperatures utilizing a newly 
developed estimation algorithm for use with conductive interstitial heating systems. The local 
minimum tumor temperature is explicitly estimated from the power required to maintain each 
member of an array of electrically heated catheters at a known temperature, in conjunction with a 
new bioheat equation-based algorithm to predict the ‘droop’ or fractional decline in tissue 
temperature between heated catheters. A closed loop controller utilizes the estimated minimum 
temperature near each catheter as a feedback parameter, which reflects variations in local blood 
flow. In response the controller alters delivered power to each catheter to compensate for 
changes in blood flow. The validity and stability of this estimation/control scheme were tested in 
computer simulations and in closed-loop control of nine patient treatments. The average 
estimation error from patient data analysis of 21 sites at which temperature was independently 
measured (three per patient) was 0.0 
o
C, with a standard deviation of 0.8 
o
C. These results 
suggest that estimation of local minimum temperature and feedback control of power delivery 





Key words: Bioheat transfer, Glioma, Glioblastoma, Hyperthermia, Simulation model, 











The clinical use of local heat therapy for the treatment of malignant disease has gained 
increasing visibility as a possible fourth modality of cancer therapy. Many clinicians have 
reported cases in which conventional therapies of surgery, radiation, or chemotherapy had failed; 
yet heat alone or heat in conjunction with conventional therapies demonstrated dramatic tumor 
regression (CRILE, 1962; LEVEEN et al., 1976; 1980; STORM et al., 1979). Yet, despite recent 
advances in equipment, technology, and techniques for treating malignant tumors with 
hyperthermia, the clinical results have remained disturbingly inconsistent (PEREZ et al., 1988). 
 
The predominant reasons for failure of current hyperthermia therapies, as demonstrated in a large 
multi-center study (PEREZ et al., 1988), would appear to be 
 
a) the lack of accurate knowledge about tumor temperature distributions 
b) the absence of precise control of tumor temperature distributions, which can vary 
widely 
c) the presence of under-heated volumes, or cold spots. 
 
These interrelated difficulties stem from an underlying lack of knowledge about tissue 
temperatures. The knowledge of temperature distributions during treatment is limited to a small 
number of implanted temperature sensors located at discrete sites. In the light of classical studies 
(CETAS et al., 1980; DEWHIRST et al., 1984) showing the minimum intratumoral temperature 
to be a highly correlated indicator of the efficacy of heat treatments in animals, it was our 
conclusion that human clinical results have probably been inconsistent because the tissue 
temperature elevations have been inconsistent. Accordingly, it has been .our goal to develop a 
system to determine and control, online and in real time, the minimum tissue temperature in a 
defined patient population receiving hyperthermia therapy for malignancy. This paper describes 
the solution of this control problem for the case of a conceptually simple, conductive interstitial 
technique. The solution allows online control of local minimum tumor temperatures throughout 
the treatment volume, even in the presence of time-varying blood flow. 
 
The conductive interstitial modality employs an array of 2.2 mm diameter interstitially implanted 
catheters (BAUMANN and ZUMWALT, 1989). The catheters contain electrically resistive 
heating elements and are implanted directly into intracranial tumors by a neurosurgeon. The 
geometry of the implantation is controlled using a template to specify the location of burr holes 
to be drilled through the skull (BAUMANN and ZUMWALT, 1989). The catheters are 
implanted such that each is equidistant from its six nearest neighbors, forming a pattern of 
equilateral triangles (Fig. 1). To maximize the delivered energy to the tumor and to minimize the 
energy delivered to adjacent normal tissue, the heating element length within the implanted 
catheter can be specified (2-8 cm) and thus tailored to tumor diameter, previously estimated from 









Fig. 1 Heating catheter implantation geometry as seen in cross section. Each triplet of catheters 
forms an equilateral triangle with 15mm sides or inter-catheter spacing. The heating catheters are 
2.2 mm in diameter. 
 
 
Application of electric current to each resistive element converts electric energy directly to heat. 
The heated catheter, in turn, warms the tissue nearby through thermal conduction and, to some 
extent, by the bulk flow of blood within the tumor. Each catheter contains a temperature sensor 
(thermistor) that is located in the center of the catheter in contact with the internal heating 
element to monitor its temperature, which can be adjusted under computer control. The relevant 
physics of heat transfer are similar in concept to those of inductively heated ferromagnetic 
thermoseeds (OLESON and CETAS, 1982). The potential for achieving computer aided, closed 
loop control of tissue temperatures is much greater with electrically heated catheters than with 







Fig. 2 The temperature distribution between a triplet of heated catheters will assume the 
presented form. The warmest area or temperature peak occurs in the center of a heating catheter, 
while the coolest area or temperature valley occurs in the center of the triplet. Zero represents the 
level of baseline arterial temperature. Here cylindrical catheters are modeled as rectangular 
solids for simplicity, causing square profiles of the thermal peaks. Catheter power is 100 mW/cm 
and blood flow is 10 ml/min/100 g. 
 
 
When the heated catheters are implanted in arrays with a nominal 15 mm inter-catheter spacing 
and triangular symmetry, the temperature profile near a triplet of catheters assumes the form 
presented in Fig. 2. A fundamental feature of the temperature profile can be described by a 
dimensionless parameter that we call thermal 'droop'. The droop is defined, when inter-catheter 
spacing is small compared with the length of the heating element, as the fractional decline in 










 .        (1) 
 
A droop of zero indicates that the local minimum tissue temperature equals the nearby source 
(catheter) temperature. This value could only occur if there is zero blood flow through the heated 
region. A droop of unity indicates that the local minimum tissue temperature is equal to arterial 
or core body temperature. This value would occur in the presence of extremely high blood flow 
or extremely wide catheter spacing. Thus, droop is a dimensionless, normalized descriptor of 
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local minimum tumor temperature, defined for the particular case of staggered arrays of 
conductive interstitial catheters. 
 
If one rearranges Equation (1), solving for the local minimum tissue temperature Tminimum, the 
result, 
 
 arterialcathetercatheterimummin TTdroopTT  ,      (2) 
 
provides an expression for local minimum tissue temperature as a function of catheter 
temperature, arterial (or core body) temperature, and droop. The problem of finding an online 
estimator of local minimum tumor temperature reduces to finding an online method of 
calculating droop, in conjunction with catheter temperature and arterial (or core body) 
temperature, both of which are easily measured. 
 
Once a method of determining droop is developed, it is then possible to incorporate closed-loop 
control using the estimated minimum temperature as a local feedback parameter for independent 
control of each heating element. Earlier work had suggested that droop can be accurately 
estimated from the steady-state catheter power and the temperature for at least some cases of 
conductive interstitial heat therapy. This approach seemed to be workable and attractive. Hence, 
the goals of the present study were to 
 
a) develop a system to control local minimum tissue temperatures based upon the 'droop' 
estimator of local minimum temperature 
b) assess the stability of the estimation/control system 





2.1 Bioheat transfer equation 
 
To determine an estimator for thermal droop during conductive interstitial hyperthermia we 
employed the bioheat transfer equation of PENNES (1948). For a control volume of tissue small 
enough so that all the thermal properties within it can be considered constants, the 










 ,      (3) 
 
where qmet is the specific rate of metabolic heat production, which is negligible in the context of 
local heat therapy for cancer, P is the power density delivered to tissue, which is zero for the 
conductive interstitial modality, K is the tissue thermal conductivity, T is the temperature of 
tissue, cb is the specific heat of blood, b is the specific flow rate of blood in capillaries, Tb, is 
the temperature of blood,  is the mass density of tissue, c is the specific heat of tissue, and t is 
time. Equation (3) governs both transient and steady-state heat transfer.  In the steady-state case, 
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and the equation simplifies to 
 
  0TTcTK bbb
2  .        (4) 
 
Literature values were used for brain tissue thermal conductivity (0.5275 W/(m 
o
C) (COOPER 
and TREZEK, 1971) and blood specific heat (3642.6 J/(kg 
o
C) (ALBRITTON, 1952). Further 
details of the computational methods used to solve this form of the bioheat equation are 
presented elsewhere (DEFORD et al., 1990). 
 
 
2.2 Local minimum temperature estimation 
 
To estimate droop, and in turn, local minimum temperatures, the bioheat transfer equation was 
utilized to characterize droop as a function of clinically measurable variables. Using the 
computer models previously described (DEFORD et al., 1990), we performed many simulations 
for arrays of heated catheters in tissue supplied by perfusions from 0 to 100 ml/min/100 g. 
Catheter powers ranged from 0 to 0.4 W/cm of catheter length. From simulation parameters and 
Equation (1) we found that droop was a simple, computable function of catheter power and 
catheter temperature, given a fixed inter-catheter spacing (Fig. 3). Noting that each curve in Fig. 
3 has a similar shape, a simple normalization was then found. After dividing the power per unit 
length delivered to a catheter by its temperature rise above arterial temperature, the curves 
collapsed to a single curve (Fig. 4). Performing a second-order polynomial regression of the 
curve in Fig. 4, we then obtained an estimation equation for droop as a function of the clinically 








Fig. 3 Droop is a polynomial function of heating catheter temperature and steady-state power per 




This estimation equation is presented in terms of a normalized power,  , (catheter power/heating 
element length/catheter temperature rise) in W/cm/
o
C for interior catheters in an array with 15 
mm spacing, namely 
 
droop = a+ b + c
2
         (5) 
 
where a= -0.0057, b=75.2 cm
o




 for the case of 15 mm inter-
catheter spacing (Fig. 1). Similar functions exist for other catheter spacings, but they are not at 
present used clinically. All the factors required to calculate  -- catheter power per unit length 
and internal temperature rise -- are readily available from hardware driving commercially 







Fig. 4 If the delivered power per unit length to the heating catheter is divided by the resultant 
internal catheter temperature rise (above arterial temperature), the multiple curves of Fig. 3, for 
15 mm catheter spacing, collapse to a single polynomial function. Performing a second-order 
regression of the resultant curve allows the development of an estimation equation for droop as a 
function of internal heating catheter temperature and power per unit length. 
 
 
Substitution of Equation (5) for droop in Equation (2) provides a simple, rapidly computable 
expression 
 
  arterialcatheter2catheterimummin TTcbaTT  ,     (6) 
 
which allows the estimation of local minimum intratumoral temperature near each implanted 
catheter. 
 
The estimation Equation (5) was determined from multiple computer simulations of the bioheat 
Equation (4), which describes the steady-state behavior of heat transfer in biological tissue. 
Steady-state conditions exist, approximately, for most of the duration of the treatment. In the 
control problem we are also concerned with the transient (heat up) phase of the catheter-tissue 
system (lasting about 10 min).  We must be assured that the temperature estimate, derived from 
Equation (6), at least tracks the true tissue temperature during the transient heat-up phase to 
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ensure a stable and accurate estimation/control system at these early times. A plot of the response 
of the catheter/tissue system to a step input in power in computer simulations (Fig. 5) 
demonstrates the difference between bioheat equation-determined local minimum temperatures 
and those estimated from Equation (6). The greatest difference between the two temperature 
curves appears when the slopes of the curves are maximum, as predicted from Equations (3) and 
(4). Although the two curves are not identical, the estimation is a good approximation to the 
bioheat equation-determined minimum tissue temperature curve, with the same curve shape and 
timing. Estimated temperature from Equation (5) was accordingly selected as a practical 






Fig. 5 A step input of 160 mW/cm to a each heating catheter (surrounded by similar heating 
catheters) and given a local perfusion of 20 ml/min/100 g yields the minimum temperature step 
response for both the bioheat equation and the minimum temperature estimation equation, based 
upon ordinary differential equations. There is little difference between the two temperature 
curves, demonstrating the accuracy of the estimation equation even during transient heating. The 







2.3 Stability of the controller design 
 
Development of the estimation Equation (6) appears to provide a route to feedback control of 
local minimum temperatures.  Evaluation of control system stability was necessary before such a 
controller could be responsibly implemented in patient treatments.  The bioheat transfer equation 
is an accurate model of tissue heat transfer (CHARNY and LEVIN, 1988; CLEGG and 
ROEMER, 1985; PANTAZATOS and CHEN, 1978), and is described in terms of partial 
differential equations (PDEs). In the context of current control theory, this poses a difficult 
problem. Tools to aid in the design and stability analysis of controllers for systems described by 
PDE's are very limited and may only be used in very specific cases (OGATA, 1970). However, 
because any estimation/control system for hyperthermia therapy will be employed in the 
treatment of human patients, it must be unconditionally stable. To further confound the problem, 
the system we seek to control is dynamic, i.e. time varying, because blood flow is time varying. 
Therefore, to design and evaluate a safe and effective control system using the conceptual tools 
presently available, an ordinary differential equation model (ODE) is highly desirable. 
 
Analysis of tissue temperature responses to step and sinusoidal power inputs to the various 
bioheat equation models allowed the identification of simple, linear ODE models that closely 
mimicked the transient response of local minimum tissue temperature, as described by the 
complete bioheat equation and Equation (6). It was discovered that the dominant mode (or time 
constant for the ODE model) of the system varied with blood flow as can be seen in Fig. 6. The 
dominant tissue mode or time constant varied from 45 sec for high blood flows (100 ml/min/100 
g) to over 2000 sec for very low blood flows (1 ml/min/100 g) (Fig. 6). It was also evident that 
the system gain (tissue temperature rise/input power) also varied with blood flow. The system 
gain increased from almost zero to about 25°C/W as blood flow varied from 100 down to 1 
ml/min/100 g. Because there is a physical separation between the hot source (catheter) and the 
location of the minimum temperature (about 8-9 mm from the source with 15 mm catheter 
spacing), there is a time delay between the application of a step change in catheter power and a 
temperature rise at a central location between catheters. This delay, found from computer 







Fig. 6 Given a step input of 160 mW/cm to each heating catheter (surrounded by similar heating 
catheters) in the presence of local perfusion ranging from 1 ml/min/100 g to 50 ml/min/100g 
yields the multiple minimum temperature responses. As blood flow increases the step response 
time decreases, and the steady-state value of the minimum temperature decreases. The baseline 
arterial temperature was 37 °C. 
 
 
The results of the step and sinusoidal simulations allowed the development of a family of first-
order ODE models to describe tissue heating; a different model for each blood flow. A classical 
transformation technique (the Laplace transform) relating time functions to frequency dependent 
functions of a complex variable, s , was used to analyze this control problem (OGATA, 1970). 
Laplace transform techniques are used extensively throughout the remainder of this manuscript. 
The application of the Laplace transform replaces functions of time by a complex function 
dependent upon frequency (OGATA, 1970). The variable  s  is defined as  + j. where  and  
are real variables, and 1j  . Employing the Laplace transform and standard methods for 
finding the inverse Laplace transform, the transient behavior of the bioheat equation can be 
emulated by a family of first-order models with a single gain and single time constant. The 












,         (7) 
 
 
where K is the open loop system gain (°C/W),  is the system time constant (in sec), and  is the 
system delay time (in sec). For a local perfusion of 1.0 ml/min/100 g, which might occur in the 










;         (8) 
 
whereas a perfusion of 20 ml/min/100 g, which represents a typical tumor blood flow 










.         (9) 
 
Table 1 presents the dependence of the open-loop gain, and the open-loop time constant on 
perfusion. Equations (7), (8) and (9) thus represent a set of perfusion-specific ODE models of a 
PDE (bioheat equation) governed system. 
 
 







Comparison of the ODE model response with the bioheat transfer equation (PDE) response 
demonstrated that the ODE models were good approximations to the system. Fig. 7 presents a 
step response of both the PDE and ODE models with a local perfusion of 10 ml/min/100 g. A 
good correlation exists between these models, adding confidence to our use of the ODE models. 
These ODE models could then be used to guide the development of the control system. The 
utility of these models does not require knowledge of the exact tissue perfusion in each particular 
case. Rather, the ODE models can serve as the basis for a worst-case analysis to design an 





Fig. 7 Given a step input of 160 m W/cm to each heating catheter (surrounded by similar heating 
catheters) and a local blood flow of 20 ml/min/100 g yields the step response presented by the 
solid curve. Applying the same step input to the ODE model determined for a 20 ml/min/100 g 
blood flow yields the step response presented by the broken curve. The two curves are almost 
identical except for the small difference during the initial 100 sec. The baseline arterial 





2.4 Practical aspects of controller design 
 
To further simplify the engineering problem, the estimation/control system was initially 
developed for use with a single hyperthermia generation system, the VH8500 system (Cook, 
Inc., Bloomington, Indiana, USA). The specifications for this control system are as follows: 
 
a) The system must be stable over the entire physiological range of blood flows (0-100 
ml/min/100 g. 
b) The system must simultaneously control multiple heating sources (currently up to 32 
catheters). 
c) It is desirable to have a rapid heat up to the pre-set point temperature (< 15min). 
d) If any overshoot of the desired minimum temperature occurs, it must be minimal and 
short lived (< 3 
o
C for < 5 min). 
e) The proposed system must operate without hardware modifications to the VH8500 
hyperthermia generation system. 
 
Since there exist many possible variations in system parameters, owing to its dynamic nature, the 
so-called optimal or state controllers (LUENBERGER, 1979) were ruled out as controller 
options. The VH8500 hyperthermia system utilizes an IBM XT compatible computer system for 
treatment planning, data storage, displaying graphics and treatment control. Therefore, a real 
limitation on the computational power exists. Considering the above specifications and 
limitations, we selected a proportional-integral (PI) control scheme (EL-HAWARY, 1984). The 
PI controller was also selected for its ability to control in the presence of system delays, 
nonlinearities, and transients that might exist during the course of actual hyperthermia treatment. 
 
The proposed estimation/control system is displayed in block diagram form in Fig. 8. 
Disturbances (such as changes in local blood flow) would enter the system after the controller. 
Without feedback it would be impossible to compensate for disturbance effects. It would be 
desirable to feed back the actual local minimum temperature, and this would make the design of 
the control system much easier. However, all true local minimum temperatures cannot be 
obtained with current technology. The task would require implantation of an intolerably large 
number of temperature sensors. Therefore, the estimated minimum temperature was used as 
feedback. The estimate, from Equation (6), tracks local disturbances very well and is a good 
candidate for use as a feedback parameter. 
 
Having selected the PI controller, control constants have to be determined that meet the 
presented specifications. Unconditional stability is of the foremost concern for this system, 
because equipment damage or patient injury is intolerable. Rather than using a classical 
definition of stability (OGATA, 1970) that would allow long-duration, high-amplitude damped 
oscillations, we specified a stability criterion that allowed a small overshoot of less than 3 °C and 
could last no more than 5 min. By these criteria, a decay ratio of greater than 0.75 was required. 
We defined the decay ratio as one minus the ratio of successive peaks or overshoots of the 
desired setpoint. Therefore, given a decay ratio of 0.75 the second peak (or overshoot) would be 








Fig. 8 The closed loop block diagram (in the s-domain) of the system model used in this study 
includes: R(s) =system input (minimum tissue temperature setpoint), E (s) = error between the 
estimated minimum temperature and the minimum temperature setpoint (Y(s)- R(s)), C(s) 
=controller used to map the error to an appropriate power intended to drive the error E(s) to zero, 
MV(s) =manipulated value or parameter varied by the controller (power delivered to the heating 
catheter), dist(s) = local disturbances such as changes in blood flow rates, Ttissue(s) =ODE model 
of the local minimum tissue temperature, G(s) =a variable that lumps the controller and tissue 
model, used only to simplify notation, Y(s) =system output (minimum tissue temperature). 
 
 
Utilizing the family of ODE models previously described (Table 1) a worst-case control situation 
was identified as the set of conditions that would most easily (with the smallest system 
disturbance) cause instability. At very low perfusions the system gain was the highest ( 25) and 
the dominant mode or time constant was the longest ( 2500 sec). These features, coupled with 
the long delay time ( 45 sec), as shown in Table 1, constitute a worst-case situation. If control 
parameters could be determined for this situation that meet all stability requirements, the same 
parameters could also be employed safely for other conditions, including all values of tissue 
blood flow > 1 ml/min/100 g. Employing the model presented by Equation (8) and the Laplace 
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where KP is the proportional gain of the controller, K1 is integration gain of the controller (EL-
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where G(s) is the open loop system transfer function from Equation (13), Y(s) is the system 
output (minimum tissue temperature), and R(s) is the system input (minimum temperature 
setpoint) as presented in Fig. 8. The controller (Equation (10)) can be thought of as a system that 
transforms the error between the desired minimum temperature and the estimated minimum 
temperature to a power (the manipulated variable or MV) in order to drive the error to zero. 
Proper selection of controller constants KP and K1 was achieved by pole placement, using the 
root locus technique, such that the desired decay ratio > 0.75 was achieved. The root locus 
method (OGATA, 1970) was also used as an analysis tool to evaluate the stability of the closed-
loop system.  
 
The root locus is a method for finding the roots of the characteristic equation, where the 
characteristic equation is the denominator of a transfer function (1 + G(s)) from Equation (14) 
and the roots of this equation are the values of  s  that cause the characteristic equation to equal 
zero. Although the open-loop roots from Equation (13) are constants, when feedback is 
introduced and the gain varied, the closed loop roots become functions that may vary over a 
large range. To determine the system stability as the system gain changes (due to changes in 
blood flow) it is useful to know how the roots (or poles) of the closed loop system vary. A 
graphical representation of the roots can be drawn in the s-plane with real values of the roots 
along the abscissa and imaginary values along the ordinate. As all roots remain negative in sign, 
i.e. the root locus does not cross the imaginary axis (ordinate), the system is stable; at the point 
where the roots cross the imaginary axis the system is marginally stable, and all points to the 
right denote system instability (MARSHALL, 1979). Thus the left half-plane may be viewed as 
an area of negative feedback and the right half-plane as a positive feedback area. Fig. 9 presents 
the relationship between the root locus plots and time domain system stability. Notice that the 
system becomes more oscillatory as the roots (or poles) move away from the real axis (in the 
root locus) signifying the presence of complex valued roots. Crossing the imaginary axis denotes 







Fig. 9 The relationship between closed-loop stability and the root locus. Temperature curve A 
corresponds to points on the root locus labeled A and so forth. Note that the temperature curves 
become more oscillatory as the poles on the root locus (corresponding points) become complex 
and move away from the real axis, and instability (sustained oscillations) occurs when the poles 








Fig. 10 The root locus of the closed loop system using the ODE tissue model for a blood flow of 
l ml/min/100 g. This was deemed the worst case, since the gain was high (24.6) and the time 
constant was long (2570 sec). The Xs denote open-loop poles and the Os denote open loop zeros 
of the system model presented in Equation (13). The boxes denote the location of the closed-loop 
poles using the presented PI controller (the operating point) with P = 0.608 and  I = 200. As the 
boxes are on the left hand side of the imaginary axis, the closed loop system is stable. The bold 
lines denote the presence of the root locus on the real axis. 
 
 
Figure 10 presents the root locus plot for the closed-loop system represented by Equation (13). 
The delay term, e
45s
 , in Equation (12), is represented by a fourth-order Pade approximation 
(MARSHALL, 1979), indicated by the multiple poles in Fig. 10. The delay actually represents an 
infinite number of new poles added to the system (MARSHALL, 1979). From the root locus 
presented in Fig. 10, one may note that for a  z  of 0.003 (from Equation 11) the closed-loop 
system gain can range from zero to 48.5 still maintaining stability. For adequate damping we 




Root loci were also generated to assess the stability of the closed loop system over the entire 
range of physiological blood flows (represented as the models that lie within the range of 
Equations (7) and (8)). Fig. 11 presents root loci for the 'best case' (represented by Equation 8), 
where best case implies the most rapid response to changes in setpoint or disturbances with 
minimal overshoot and no instability, while worst case (Equation (13) and Fig. 10) implies the 
converse. The root locus remains very near the real axis (abscissa) for the best case, 
demonstrating a very high decay ratio (i.e. little or no overshoot, and a rapid response). The root 
locus in the worst case begins to approach the imaginary axis (ordinate) with complex roots, but 





Fig. 11 The root locus of the closed loop system using the ODE tissue model for a blood flow of 
100 ml/min/100 g. This was deemed the best case, because the gain was low (0.12) and the time 
constant was short (43 sec). The Xs denote the location of open-loop poles and the Os denote the 
location of open-loop zeros of the system model. The boxes denote the location of closed-loop 
poles using the PI controller with P = 0.608 and I= 200. Since the boxes are on the left hand side 
of the imaginary axis, the closed-loop system is stable. The bold lines denote the presence of the 





2.5 Clinical methods and data analysis 
 
Having developed the worst-case controller based upon a defined family of linear ODE models, 
we tested the controller performance, first in computer simulations and then in clinical settings 
(Missouri Baptist Medical Center or St Luke's West Hospital, St Louis, Missouri, USA). The 
estimation/control system was first analyzed in computer simulations using the bioheat transfer 
equation. These simulations demonstrated that stability was maintained in the presence of a large 
step increase or a decrease in effective perfusion (step changes > 60 ml/min/100 g), thereby 
verifying that the estimation/control system could be used safely and effectively in the clinic. 
 
To assess the validity and stability of the proposed system, eight patients were treated (one 
patient was treated twice) with the presented system. Each treatment was monitored to ensure 
system stability then retrospectively analyzed to determine the minimum temperature accuracy. 
Each patient was treated at Missouri Baptist Medical Center or St Luke's West Hospital in St 
Louis, Missouri, USA, with approval from their Institutional Review Boards (IRBs) and an 
investigational device exemption from the US Food & Drug Administration. There were six male 
and two female patients in this study, ranging in age from 41 to 67 years. The tumor types 
diagnosed at the time of hyperthermia treatment included four glioblastoma multiformes, three 
anaplastic astrocytomas and one metastatic lesion. The hyperthermia catheters were implanted as 
described previously (BAUMANN and ZUMWALT, 1989). The number of heating catheters 
implanted varied with tumor size and ranged from 6 to 17 with a median value of 11. 
 
To monitor intratumoral temperatures between the implanted heat generating catheters, small 
diameter (1.2 mm) temperature sensing catheters (containing only thermistors) were implanted. 
The temperatures from these sensors were used as comparison values to determine the accuracy 
and stability of the estimation equation and controller. The General Electric 9800 CT scanner 
and computer were employed to determine the position of the heating and temperature sensing 
catheters. Sequential non-overlapping coronal CT scans with a slice thickness of 3 mm were 
obtained immediately after implantation; then, employing the CT computer, sagittal 
reconstructions were performed to measure the implantation geometry in cross section. Only 
those temperature sensing catheters that were within 3 mm of the center of a triplet of heating 
catheters were included in subsequent analysis. 
 
During treatment the hyperthermia system (VH8500) acquires and stores operational and patient 
data for retrospective analysis. Included in the data stored are catheter current and voltage levels, 
treatment time, catheter power levels and individual catheter temperatures. Steady-state values of 
estimated minimum temperature and the corresponding measured minimum temperatures were 
retrospectively compared at multiple time instants during the three hour treatment. System 
stability was monitored during each patient treatment to ensure the safety of the patient. To study 
the occurrence and effect of local disturbances on the estimation/control system, retrospective 
analysis employing computer aided reconstructions of patient treatments were performed as 







3.1 Engineering studies 
 
The estimation/control system was evaluated both in computer simulations and in the clinic. 
Results of computer simulations employing the transient bioheat transfer equation and the 
estimation/control system verified the accuracy and stability of the proposed system before 
clinical testing. Table 2 summarizes the simulated temperature estimation error, minimum 
temperature overshoot and the decay ratio for various local perfusions ranging from 1 
ml/min/100 g to 100 ml/min/100 g (a much wider variation of blood flows than expected in 
patients). For each perfusion value tested over the above range, the estimation/control system 
proved to be accurate and stable--meeting or exceeding the design specifications. 
 
 




The estimation equation (Equation (6)) proved, in computer simulations, to be very accurate 
during steady state with a mean estimation error of 0.04 
o
C and standard deviation of 0.11 
o
C 
over the range of perfusions from 1 to 80 ml/min/100 g. 
 
At perfusions greater than 80 ml/min/100 g there was little temperature rise between catheters 
and therefore temperature estimation errors were unobtainable. During transients, such as the 
initial heat-up of the catheters or during changes in capillary blood flow, the estimation of 
minimum temperature always led the actual minimum temperature in time. That is, the estimated 
minimum temperature would overshoot the minimum temperature, as seen in Fig. 5. However, 
the estimated minimum temperature did closely track the minimum temperature even during 
large disturbances. Fig. 12 presents the response, as modeled in computer simulations, of the 
bioheat equation, of the variation of the estimation/control system in the presence of a large step 
increase in perfusion from an initial value of 10 ml/min/100 g to 40 ml/min/100 g. Notice that 






Fig. 12 The response of the closed loop system to a large disturbance in local blood flow, as 
modeled by the transient bioheat transfer equation, using the PI controller and the minimum 
temperature estimation equation.  Given an initial perfusion of 10 ml/min/100 g and a minimum 
temperature setpoint of 43 
o
C, the minimum temperature was controlled to the setpoint.  After 
2000 sec at the initial blood flow rate (10 ml/min/100 g) the perfusion was increased in step 
fashion to 40 ml/min/100 g.  Note that after a dramatic drop in minimum temperature the 
minimum temperature returned to the desired setpoint without loss of stability. Also note that the 
estimated temperature, derived from the steady-state bioheat equation, tracked the actual 
temperature from the transient bioheat equation model with only small deviations.  Solid curve ~ 
bioheat equation.  Dashed curve ~ estimated equation. 
 
 
3.2 Clinical data 
 
The presented estimation/control system has been tested in nine patient treatments with no 
evidence of instability or large temperature estimation errors. Stability in each treatment was 
maintained and retrospective analysis of the temperature estimation (during steady state) 
revealed an average estimation error of 0.0 
o
C with a standard deviation of 0.8 °C. The design 
specifications were met or exceeded in all patient treatments. No patient treatment demonstrated 
any sign of instability in any of the nine patient treatments in which this system was employed. 
Specifically, the design goals included a decay ratio greater than 0.75 and a heat-up time of less 
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than 15 min. A decay ratio of greater than 0.92 was found in each patient treatment and the time 
required to achieve the therapeutic temperature setpoint, as determined by the estimation 
equation, was always less than 10 min, with an average heat-up time of 8.3 min and a standard 





This paper presents the first report of fully closed-loop control of hyperthermia treatment of a 
complete tumor volume using multipoint feedback control. Previous attempts at feedback control 
in hyperthermia have adjusted the total or the local power delivery to achieve the desired 
temperature at a single selected temperature probe (MAGIN et al., 1982), and control of the 
entire temperature distribution was not attempted. 
 
Because of the conceptual simplicity of conductive interstitial hyperthermia, and similarity of 
local temperature distributions around each heated catheter, a single algorithm can be applied to 
all the catheters in the array to good effect. Control of heated catheters near large blood vessels 
or exterior in the implanted array, although not specifically modeled, are to a large extent 
self-compensating, because the greater convective heat loss to a large vessel or the greater 
conductive heat loss from the tumor edge toward the periphery is detected as increased capillary 
perfusion by the estimation algorithm. This easily implemented control scheme holds promise 
for eliminating problems of cold spots with attendant treatment failures. Overheating of normal 
tissues (a major limitation with feedback control of external beam techniques) does not occur 
with interstitial conductive heating, because heated catheters are implanted directly into tumor 
tissue and blood flow outside the tumor volume provides a good heat sink, thereby keeping 
nearby normal tissue cool. 
 
Hyperthermia as a treatment modality for malignant tumors does have a strong biological 
rationale. Heat is known to kill cells exponentially as a function of either time or temperature. 
However, when the treatment temperature remains near the thermal death threshold, even small 
temperature differences can lead to large differences in cytopathological effect (SAPARETO, 
1982). Thus, effective hyperthermia treatments depend on accurate control of tissue temperatures 
in order to abolish cold spots (underheated volumes). The ability to estimate local minimum 
temperatures from clinically available data is the first, and most important, step to this 
technically attractive route of online, closed-loop computer control of minimum intratumoral 
temperatures. 
 
We found the bioheat transfer equation to be a good model of heat transfer in biological tissues, 
as have other authors of previous reports (CHARNY and LEVIN, 1988; CLEGG and ROEMER, 
1985; OLESON et al., 1984; PANTAZATOS and CHEN, 1978). A major practical drawback of 
the bioheat equation, however, is the computational time required to solve it, especially when a 
large number of nodes or control volumes are employed, as is necessary in the presence of steep 
thermal gradients characteristic of the conductive interstitial technique. To circumvent this 
limitation we have used offline solutions of the bioheat equation and condensed the results to 
produce a rapidly computable online estimation equation. These estimations provide a key to 
effective computer-assisted hyperthermia therapy under feedback control that promises to 
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minimize cold spots and associated treatment failures. By employing the estimation equation 
presented and ODE models of tissue heat transfers for the specific case of conductive interstitial 
hyperthermia, a simple and stable estimation/control system has been developed and tested. This 
system requires little computational overhead, yet provides a level of treatment control 
heretofore impossible. The accuracy and precision of these estimated temperatures seem 
sufficient for practical clinical use in conductive interstitial therapy of intracranial tumors. 
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